Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mutation of K-RAS, CDKN2A, SMAD4 and TP53 in Pancreatic Cancer: Role of Liquid Biopsy in Preoperative Diagnosis

NCT03524677 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT03524677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03524677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mutation of K-RAS, CDKN2A, SMAD4 and TP53 in Pancreatic Cancer: Role of Liquid Biopsy in Preoperative Diagnosis
Lead sponsor
University of Roma La Sapienza
Phase
Observational
Overall status
Unknown status
Start date
January 23, 2019
Completion date
January 31, 2020
Enrollment
50 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer